Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
Arylamine compounds, such as sulfamethoxazole (SMX) and dapsone (DDS), are metabolized in epidermal keratinocytes to arylhydroxylamine metabolites that auto-oxidize to arylnitroso derivatives, which in turn bind to cellular proteins and can act as antigens/immunogens. Previous studies have demonstrated that neither cytochromes P450 nor cyclooxygenases mediate this bioactivation in normal human epidermal keratinocytes (NHEKs). In this investigation, we demonstrated that methimazole (MMZ), a prototypical substrate of the flavin-containing monooxygenases (FMOs), attenuated the protein haptenation observed in NHEKs exposed to SMX or DDS. In addition, recombinant FMO1 and FMO3 were able to bioactivate both SMX and DDS, resulting in covalent adduct formation. Western blot analysis confirmed the presence of FMO3 in NHEKs, whereas FMO1 was not detectable. In addition to MMZ, 4-aminobenzoic acid hydrazide (ABH) also attenuated SMX- and DDS-dependent protein haptenation in NHEKs. ABH did not alter the bioactivation of these drugs by recombinant FMO3, suggesting its inhibitory effect in NHEKs was due to its known ability to inhibit peroxidases. Studies confirmed the presence of peroxidase activity in NHEKs; however, immunoblot analysis and reverse transcription-polymerase chain reaction indicated that myeloperoxidase, lactoperoxidase, and thyroid peroxidase were absent. Thus, our results suggest an important role for FMO3 and yet-to-be identified peroxidases in the bioactivation of sulfonamides in NHEKs.
Vyas
Piyush M
PM
Division of Pharmaceutics, College of Pharmacy, University of Iowa, Iowa City, Iowa, USA.
Roychowdhury
Sanjoy
S
Koukouritaki
Sevasti B
SB
Hines
Ronald N
RN
Krueger
Sharon K
SK
Williams
David E
DE
Nauseef
William M
WM
Svensson
Craig K
CK
D002478:Cells, Cultured; D003622:Dapsone / Q000009:adverse effects / Q000378:metabolism*; D006241:Haptens / Q000378:metabolism*; D006801:Humans; D007453:Iodide Peroxidase / Q000502:physiology; D015603:Keratinocytes / Q000378:metabolism*; D007784:Lactoperoxidase / Q000502:physiology; D010105:Oxygenases / Q000502:physiology*; D009195:Peroxidase / Q000502:physiology; D010544:Peroxidases / Q000502:physiology*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000378:metabolism*
D006241:Haptens; D003622:Dapsone; D007784:Lactoperoxidase; D010544:Peroxidases; D009195:Peroxidase; D007453:Iodide Peroxidase; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); D013420:Sulfamethoxazole